ImmunityBio, a MOX Sister Company, Enters Phase 1 Trial for COVID-19 Vaccine
Insightful discussions and detailed descriptions of how the ImmunityBio COVID-19 vaccine research led by Dr. Patrick Soon-Shiong, M.D. Chairman and CEO of NantWorks, and founder and MOX owner, is different from other vaccine candidates.